MAPT and Alzheimer disease: WB analysis revealed a significant increase in total tau levels (HT7) in diabetic AD samples (Figure 1a1, a3) and an increase in tau phosphorylation at residues Ser202/Thr205 and pThr231 (recognized by the AT8 and AT180 antibody respectively), though the increase in tau phosphorylation was not significant.